Prediction of PD-L1 expression in NSCLC patients using PET/CT radiomics and prognostic modelling for immunotherapy in PD-L1-positive NSCLC patients.
Peng M, Wang M, Yang X, Wang Y, Xie L, An W, Ge F, Yang C, Wang K
Peng M, Wang M, Yang X, Wang Y, Xie L, An W, Ge F, Yang C, Wang K
N JS, Ayothi S
Karimijafarbigloo S, Azad R, Kazerouni A, Merhof D
Baudin PY, Balsiger F, Beck L, Boisserie JM, Jouan S, Marty B, Reyngoudt H, Scheidegger O
Cao Y, Zhang J, Ma Y, Zhang S, Li C, Liu S, Chen F, Huang P
Singh M, Jester N, Lorr S, Briano A, Schwartz N, Mahajan A, Chiang V, Tommasini SM, Wiznia DH, Buono FD
Sagawa H, Sakakura Y, Hanazawa R, Takahashi S, Wakabayashi H, Fujii S, Fujita K, Hirai S, Hirakawa A, Kono K, Sumita K
Feher B, Werdich AA, Chen CY, Barrow J, Lee SJ, Palmer N, Feres M
Deniz HA, Bayrakdar İŞ, Nalçacı R, Orhan K
Hage Chehade A, Abdallah N, Marion JM, Hatt M, Oueidat M, Chauvet P
Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.
We respect your privacy. Unsubscribe at any time.